Centre Hospitalier Universitaire de Lille

Lille 59037

5 studies enrolling now · 17 studies all time

What they study most

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult Disease, Advanced Malignant Neoplasm, Advanced Solid Tumor, Anemia, COVID-19, Cardiovascular Diseases, Coronary Artery Disease, Critically Ill, Cushing's Disease

Studies at this site

• Prophylactic Reinforcement of Ventral Abdominal Incisions Trial — Recruiting now
• A Trial of Lu AG13909 in Adult Participants With Cushing's Disease — Recruiting now
• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
• A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS) — Recruiting now
• Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment — Recruiting now
• Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) — Running, not enrolling
• Precise Procedural and PCI Plan (P4) — Running, not enrolling
• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
• A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). — Completed
• Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) — Running, not enrolling
• Myocardial Ischemia and Transfusion — Completed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed
• Acute Encephalopathy in Critically Ill Patients With COVID-19 — Status unconfirmed